Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to Infection

  • Iborra, Salvador
  • Martinez-Lopez, Maria
  • Cueto, Francisco J.
  • Conde-Garrosa, Ruth
  • del Fresno, Carlos
  • Izquierdo-Fernandez, Helena Maria
  • Abram, Clare L
  • Mori, Daiki
  • Campos-Martín, Yolanda
  • Reguera, Rosa María
  • Kemp, Benjamin
  • Yamasaki, Sho
  • Robinson, Matthew J
  • Soto, Manuel
  • Lowell, Clifford A
  • Sancho, David
C-type lectin receptors sense a diversity of endogenous and exogenous ligands that may trigger differential responses. Here, we have found that human and mouse Mincle bind to a ligand released by Leishmania, a eukaryote parasite that evades an effective immune response. Mincle-deficient mice had milder dermal pathology and a tenth of the parasite burden compared to wild-type mice after Leishmania major intradermal ear infection. Mincle deficiency enhanced adaptive immunity against the parasite, correlating with increased activation, migration, and priming by Mincle-deficient dendritic cells (DCs). Leishmania triggered a Mincle-dependent inhibitory axis characterized by SHP1 coupling to the FcRγ chain. Selective loss of SHP1 in CD11c+ cells phenocopies enhanced adaptive immunity to Leishmania. In conclusion, Leishmania shifts Mincle to an inhibitory ITAM (ITAMi) configuration that impairs DC activation. Thus, ITAMi can be exploited for immune evasion by a pathogen and may represent a paradigm for ITAM-coupled receptors sensing self and non-self.
Repisalud
Publication Artículo científico (JournalArticle)

Signalling versatility following self and non-self sensing by myeloid C-type lectin receptors

  • Iborra, Salvador
  • Sancho, David
Among myeloid immune receptors, C-type lectin receptors (CLRs) have a remarkable capacity to sense a variety of self and non-self ligands. The coupling of CLRs to different signal transduction modules is influenced not only by the receptor, but also by the nature, density and architecture of the ligand, which can affect the rate of receptor internalization and trafficking to diverse intracellular compartments. Understanding how the variety of self and non-self ligands triggers differential CLR signalling and function presents a fascinating biological challenge. Non-self ligands usually promote inflammation and immunity, whereas self ligands are frequently involved in communication and tolerance. But pathogens can mimic self-inhibitory signals to escape immune surveillance, and endogenous ligands can contribute to the sensing of pathogens through CLRs. In this review, we survey the complexity and flexibility in functional outcome found in the myeloid CLRs, which is not only based on their differing intracellular motifs, but is also conditioned by the physical nature, affinity and avidity of the ligand. (C) 2014 The Authors. Published by Elsevier GmbH.
Repisalud
Publication Artículo científico (JournalArticle)

Batf3-dependent CD103(+) dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice

  • Martinez-Lopez, Maria
  • Iborra, Salvador
  • Conde-Garrosa, Ruth
  • Sancho, David
The role of different DC subsets in priming and maintenance of immunity against Leishmania major (L. major) infection is debated. The transcription factor basic leucine zipper transcription factor, ATF-like 3 (Batf3) is essential for the development of mouse CD103(+) DCs and some functions of CD8(+) DCs. We found that CD103(+) DCs were significantly reduced in the dermis of Batf3-deficient C57BL/6 mice. Batf3(-/-) mice developed exacerbated and unresolved cutaneous pathology following a low dose of intradermal L. major infection in the ear pinnae. Parasite load was increased 1000-fold locally and expanded systemically. Batf3 deficiency did not affect L. major antigen presentation to T cells, which was directly exerted by CD8(-) conventional DCs (cDCs) in the skin draining LN. However, CD4(+) T-cell differentiation in the LN and skin was skewed to nonprotective Treg- and Th2-cell subtypes. CD103(+) DCs are major IL-12 producers during L. major infection. Local Th1 immunity was severely hindered, correlating with impaired IL-12 production and reduction in CD103(+) DC numbers. Adoptive transfer of WT but not IL-12p40(-/-) Batf3-dependent DCs significantly improved anti-L. major response in infected Batf3(-/-) mice. Our results suggest that IL-12 production by Batf3-dependent CD103(+) DCs is crucial for maintenance of local Th1 immunity against L. major infection.
Repisalud
Publication Artículo científico (JournalArticle)

The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice

  • Iborra, Salvador
  • Izquierdo-Fernandez, Helena Maria
  • Martinez-Lopez, Maria
  • Blanco-Menendez, Noelia
  • Reis e Sousa, Caetano
  • Sancho, David
In order to prime T cells, DCs integrate signals emanating directly from pathogens and from their noxious action on the host. DNGR-1 (CLEC9A) is a DC-restricted receptor that detects dead cells. Therefore, we investigated the possibility that DNGR-1 affects immunity to cytopathic viruses. DNGR-1 was essential for cross-presentation of dying vaccinia virus-infected (VACV-infected) cells to CD8(+) T cells in vitro. Following injection of VACV or VACV-infected cells into mice, DNGR-1 detected the ligand in dying infected cells and mediated cross-priming of anti-VACV CD8(+) T cells. Loss of DNGR-1 impaired the CD8+ cytotoxic response to VACV, especially against those virus strains that are most dependent on cross-presentation. The decrease in total anti-VACV CTL activity was associated with a profound increase in viral load and delayed resolution of the primary lesion. In addition, lack of DNGR-1 markedly diminished protection from infection induced by vaccination with the modified vaccinia Ankara (MVA) strain. DNGR-1 thus contributes to anti-VACV immunity, following both primary infection and vaccination. The non-redundant ability of DNGR-1 to regulate cross-presentation of viral antigens suggests that this form of regulation of antiviral immunity could be exploited for vaccination.
Repisalud
Publication Tesis doctoral (DoctoralThesis)

Polybacterial mucosal vaccine protects against viral respiratory infections and induces trained immunity

  • Brandi, Paola
Recurrent respiratory tract infections (RRTI) are very frequent in childhood due to the immature state of the immune system and the traditional therapeutic strategies just rely on antibiotic treatments. However, the etiology of RRTIs is diverse, with viruses being the most common cause of the disease. Thus, alternative approaches that tackle this heal¬th issue are needed. In this direction, several studies have shown that bacterial preparations provide protection against RRTI through the modulation of both cellular and humoral responses. MV130 is a sublingual preparation of different whole inactivated bacteria that are frequently present in the human respiratory tract. Its efficacy against RRTIs has been already demonstra¬ted both in adults and in children, but its mechanism of action remains unexplored. Herein, we observed that MV130 treatment in mice provided protection against both Vaccinia and Influen¬za A respiratory infections and this was reflected into less weight loss and better survival than control mice. Indeed, MV130-treated mice showed a reduced viral load in the lungs at day three post infection. Moreover, MV130 treatment causes a general infiltration of both myeloid and lymphoid cell populations in the lungs. Several studies indicate that certain microbial stimuli can induce functional, metabolic and epigenetic changes in innate immune cells resulting in long-las¬ting improved response to a secondary infection. This phenomenon is termed trained immunity. Therefore, we hypothesized that MV130 could confer protection by inducing trained immunity. We observed that MV130 provides protection to mice against systemic Candida albicans infec¬tion, a benchmark in vivo model of trained immunity. Moreover, the protective effect of MV130 was reproduced in mice that lack T and B lymphocytes. Following metformin treatment, which inhibits the mTOR pathway and thus impairs trained immunity, mice pretreated with MV130 lost the protection against Influenza A respiratory infection. MV130 is also able to educate myeloid progenitors, which can give rise in vitro to trained mature cells. Finally, we found that MV130 is able to induce trained immunity in human monocytes, promoting metabolic and epigenetic mo¬dulation and enhanced cytokine production. Thus, these results highlight the important role of MV130 mediated-cross protection through generation of innate immune memory.